Lorcaserin

Lorcaserin

SCHEMBL5318608

CC1CNCCc2ccc(Cl)cc21.CC1CNCCc2ccc(Cl)cc21.Cl.Cl.O

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

HTR2C

The experimentally established mechanism targets of Lorcaserin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HTR2C known ✓ P28335 20/20 0.94
HTR2A P28223 20/20 0.94
HTR2B P41595 18/20 0.94
ADRB1 P08588 1/20 0.94
HTR1A P08908 1/20 0.94
ADRA2A P08913 1/20 0.94
ADRA2B P18089 1/20 0.94
ADRA2C P18825 1/20 0.94
CNR1 P21554 1/20 0.94
SLC6A2 P23975 1/20 0.94
SLC6A4 P31645 1/20 0.94
HRH1 P35367 1/20 0.94
KCNH2 Q12809 1/20 0.94

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lorcaserin SCHEMBL30418169 1.00 HTR2A (0.94) HTR2AHTR2CHTR2BADRB1HTR1A
Lorcaserin SCHEMBL173222 1.00 HTR2A (0.94) HTR2AHTR2CHTR2BADRB1HTR1A
Lorcaserin SCHEMBL19179796 1.00 HTR2A (0.94) HTR2AHTR2CHTR2BADRB1HTR1A
Lorcaserin SCHEMBL173223 1.00 HTR2A (0.94) HTR2AHTR2CHTR2BADRB1HTR1A
Lorcaserin SCHEMBL3757691 1.00 HTR2A (0.94) HTR2AHTR2CHTR2BADRB1HTR1A
Lorcaserin SCHEMBL5318606 1.00 HTR2A (0.94) HTR2AHTR2CHTR2BADRB1HTR1A
Lorcaserin SCHEMBL174044 0.98 HTR2A (0.97) HTR2AHTR2CHTR2BADRB1HTR1A
Lorcaserin SCHEMBL174046 0.98 HTR2A (0.97) HTR2AHTR2CHTR2BADRB1HTR1A
Lorcaserin SCHEMBL1954700 0.98 HTR2A (0.97) HTR2AHTR2CHTR2BADRB1HTR1A
Lorcaserin SCHEMBL173899 0.98 HTR2A (0.97) HTR2AHTR2CHTR2BADRB1HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115784911-A Synthetic method of 1- [2- (4-chlorophenyl) -ethylamino ] -2-propanol 山东省药学科学院 2023-03-14 CN disclosed
CN-112358406-A Preparation method of lorcaserin intermediate 山东省药学科学院 2021-02-12 CN disclosed
CN-106478506-B The preparation method of half light green Ka Selin hydrochloride 山东科兴生物制品有限公司 2019-03-15 CN disclosed
CN-106478506-A The preparation method of half light green Ka Selin hydrochlorate 山东科兴生物制品有限公司 2017-03-08 CN disclosed
EP-1838677-A2 CRYSTALLINE FORMS OF (R)-8-CHLORO-1-METHYL- 2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE HYDROCHLORIDE Arena Pharmaceuticals, Inc. (US) 2007-10-03 EP disclosed
WO-2006069363-A2 CRYSTALLINE FORMS OF (R)-8-CHLORO-1-METHYL- 2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE HYDROCHLORIDE ARENA PHARMACEUTICALS, INC. (US) 2006-06-29 WO disclosed